Effectiveness and Safety of a Novel Intravascular Lithotripsy System in Severely Calcified Coronary Lesions(COCALP)

NACompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

November 29, 2022

Study Completion Date

May 31, 2023

Conditions
Calcified Coronary Lesions
Interventions
DEVICE

IVL(Sonico-CX)

SONICO-CX® balloon matched 1:1 to the reference vessel diameter, was advanced to the target lesion to pretreat

Trial Locations (11)

200032

Zhongshan Hospital, Fudan University, Shanghai

200065

Tongji Hospital, Tongji University, Shanghai

210009

Zhongda Hospital, Southeast University, Nanjing

310009

The Second Affiliated Hospital, Zhejiang University, Hangzhou

310020

Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou

315000

Ningbo First Hospital University, Ningbo

510080

Guangdong Provincial People's Hospital, Guangzhou

510120

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

514000

Meizhou People's Hospital, Meizhou

563000

Affiliated Hospital of Zunyi Medical University, Zunyi

[email protected]

First Affiliated Hospital of University of Science and Technology of China,, Hefei

All Listed Sponsors
lead

Spectrumedics Medical Technology(Shanghai)Co.,Ltd

INDUSTRY

NCT06787547 - Effectiveness and Safety of a Novel Intravascular Lithotripsy System in Severely Calcified Coronary Lesions(COCALP) | Biotech Hunter | Biotech Hunter